feed,title,long_url,short_url
MX,FDA approves pembrolizumab for resectable head and neck cancer with PD-L1 expression,https://medicalxpress.com/news/2025-06-fda-pembrolizumab-resectable-neck-cancer.html,https://da.gd/YOopH
